GuLF Study
GuLF Study
The GuLF Study, short for Gulf Long-term Follow-up Study, is a research initiative conducted by the National Institute of Environmental Health Sciences (NIEHS) to assess the potential health effects of the Deepwater Horizon oil spill on cleanup workers and volunteers.
Background
The Deepwater Horizon oil spill, also known as the BP oil spill, occurred in April 2010 when an offshore drilling rig exploded in the Gulf of Mexico, resulting in one of the largest oil spills in history. In response to the disaster, the GuLF Study was launched to monitor and evaluate the health of individuals involved in the cleanup efforts.
Objectives
The primary objective of the GuLF Study is to investigate the short-term and long-term health effects of exposure to oil and dispersants used during the cleanup operations. By collecting data on participants' health status over time, researchers aim to identify any potential associations between exposure to oil-related chemicals and adverse health outcomes.
Study Design
The GuLF Study is a prospective cohort study, meaning that participants are followed over an extended period to track changes in their health status. Participants undergo regular health assessments, including physical examinations, laboratory tests, and surveys to gather information on their health history and potential exposures.
Findings
To date, the GuLF Study has generated valuable insights into the health effects of the Deepwater Horizon oil spill. Preliminary findings suggest that individuals involved in the cleanup efforts may be at increased risk of respiratory problems, skin conditions, and mental health issues compared to the general population.
Future Directions
As the GuLF Study continues, researchers plan to expand their investigations to explore additional health outcomes and potential risk factors associated with oil spill exposure. By conducting long-term follow-up assessments, the study aims to provide evidence-based recommendations for mitigating the health impacts of future oil spill disasters.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD